溴隐亭对高催乳素血症女性催乳素的广泛抑制作用：急性和慢性给予溴隐亭后血清催乳素及溴隐亭水平的研究 - Suppr

Suppr

超能文献

A broad spectrum of prolactin suppression by bromocriptine in hyperprolactinemic women: a study of serum prolactin and bromocriptine levels after acute and chronic admknistration of bromocriptine.

作者信息

Thorner M O, Schran H F, Evans W S, Rogol A D, Morris J L, MacLeod R M

出版信息

J Clin Endocrinol Metab. 1980 Jun;50(6):1026-33. doi: 10.1210/jcem-50-6-1026.

DOI:10.1210/jcem-50-6-1026

PMID:7189523

Abstract

摘要

相似文献

A broad spectrum of prolactin suppression by bromocriptine in hyperprolactinemic women: a study of serum prolactin and bromocriptine levels after acute and chronic admknistration of bromocriptine.溴隐亭对高催乳素血症女性催乳素的广泛抑制作用：急性和慢性给予溴隐亭后血清催乳素及溴隐亭水平的研究

J Clin Endocrinol Metab. 1980 Jun;50(6):1026-33. doi: 10.1210/jcem-50-6-1026.

Dopaminergic mechanisms and luteinizing hormone secretion. I. Acute administration of the dopamine agonist bromocriptine does not inhibit luteinizing hormone release in hyperprolactinemic women.多巴胺能机制与促黄体生成素分泌。I. 多巴胺激动剂溴隐亭的急性给药并不抑制高泌乳素血症女性的促黄体生成素释放。

J Clin Endocrinol Metab. 1980 Jan;50(1):103-7. doi: 10.1210/jcem-50-1-103.

Immunoreactive prolactin in breast milk and plasma of women with hyperprolactinemia, galactorrhea and menstrual dysfunction.高催乳素血症、溢乳和月经功能障碍女性母乳和血浆中的免疫反应性催乳素。

Int J Fertil. 1986 Mar-Apr;31(1):67-70.

Hyperprolactinemic primary amenorrhea: case report with successful prolactin-lowering treatment and review of the literature.高催乳素血症性原发性闭经：催乳素降低治疗成功的病例报告及文献综述

Gynecol Obstet Invest. 1980;11(6):317-26. doi: 10.1159/000299853.

[Our experiences in the determination of prolactin by radioimmunoassay (author's transl)].[我们用放射免疫分析法测定催乳素的经验（作者译）]

God Zb Med Fak Skopje. 1979 Jan;25:267-71.

[Hyperprolactinemia and adrenal androgens].

Riv Ital Ginecol. 1980;59(4-5):351-6.

[Treatment of hyperprolactinemic conditions with bromoergocryptine].

Zentralbl Gynakol. 1978;100(22):1501-7.

2alpha-bromoergocryptine in the management of the amenorrhea-galactorrhea syndrome. Clinical and endocrinological evaluation of response to treatment.

Acta Eur Fertil. 1978 Mar;9(1):21-9.

[Bromocriptine treatment of amenorrhea with hyperprolactinemia and galactorrhea].

Horumon To Rinsho. 1983 Jan;31(1):95-9.

Serum levels of prolactin in basal conditions and after administration of 2-bromo-5alpha-ergocryptine in normal and galactorrheic subjects.正常和溢乳症患者基础状态下及给予2-溴-5α-麦角隐亭后的血清催乳素水平。

Fertil Steril. 1978 Jan;29(1):26-9. doi: 10.1016/s0015-0282(16)43031-1.

引用本文的文献

F-fallypride and C-methionine positron emission tomography/computed tomography for the study of prolactinomas and nonfunctioning pituitary adenomas: A case series.F-氟代去甲丙咪嗪和C-蛋氨酸正电子发射断层扫描/计算机断层扫描用于泌乳素瘤和无功能垂体腺瘤的研究：病例系列

World J Nucl Med. 2021 Mar 15;20(3):286-293. doi: 10.4103/wjnm.WJNM_83_20. eCollection 2021 Jul-Sep.

The therapeutic effect of bromocriptine in combination with spironolactone in patients with primary aldosteronism: a hypothesis generating pilot study.溴隐亭联合螺内酯治疗原发性醛固酮增多症患者的疗效：一项产生假设的初步研究。

Oncotarget. 2017 Sep 6;8(44):77609-77621. doi: 10.18632/oncotarget.20670. eCollection 2017 Sep 29.

Management of medically refractory prolactinoma.药物难治性泌乳素瘤的管理

J Neurooncol. 2014 May;117(3):421-8. doi: 10.1007/s11060-013-1270-8. Epub 2013 Oct 22.

Pharmacologic resistance in prolactinoma patients.泌乳素瘤患者的药理耐药性。

Pituitary. 2005;8(1):43-52. doi: 10.1007/s11102-005-5085-2.

Dopamine resistance of prolactinomas.催乳素瘤的多巴胺抵抗

Pituitary. 2003;6(1):19-27. doi: 10.1023/a:1026225625897.

Medical management of prolactin-secreting pituitary adenomas.催乳素分泌型垂体腺瘤的医学管理。

Pituitary. 2002;5(2):55-65. doi: 10.1023/a:1022375429083.

Quinagolide in the management of prolactinoma.喹高利特在泌乳素瘤治疗中的应用

Pituitary. 2000 Dec;3(4):239-49. doi: 10.1023/a:1012884214668.

Microdialysis study of bromocriptine and its metabolites in rat pituitary and striatum.

Eur J Drug Metab Pharmacokinet. 2000 Apr-Jun;25(2):79-84. doi: 10.1007/BF03190071.

Use of cabergoline in the long-term treatment of hyperprolactinemic and acromegalic patients.卡麦角林在高催乳素血症和肢端肥大症患者长期治疗中的应用。

J Endocrinol Invest. 1997 Oct;20(9):537-46. doi: 10.1007/BF03348016.

Imaging of dopamine D2 and somatostatin receptors in vivo using single-photon emission tomography in a patient with a TSH/PRL-producing pituitary macroadenoma.使用单光子发射断层扫描对一名分泌促甲状腺激素/催乳素的垂体大腺瘤患者进行体内多巴胺D2和生长抑素受体成像。

Eur J Nucl Med. 1993 Jun;20(6):555-61. doi: 10.1007/BF00175168.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验